(b) any Restricted Payment pursuant to items (iii) and/or (iv) above may be made by the Issuer, provided that at the time of the payment (i) the Incurrence Test is satisfied (calculated on a pro forma basis including the relevant payment), (ii) the aggregate amount of such payments in any fiscal year does not exceed USD 10,000,000, and (iii) it is expected that following completion of the payment, the Group's aggregate cash balance will amount to no less than USD 5,000,000; or
12.2
Nature of business
The Issuer shall procure that no substantial change is made to the general nature of the business carried on by the Issuer and the Subsidiaries as of the Issue Date if such substantial change would have a Material Adverse Effect.
12.3
Financial Indebtedness
The Issuer shall not, and shall procure that none of the Subsidiaries will, incur any new Financial Indebtedness, or maintain or prolong any existing Financial Indebtedness, provided however that the Issuer and the Subsidiaries have a right to incur, maintain or prolong any Financial Indebtedness that constitutes Permitted Debt, if such Permitted Debt is incurred on market terms (or better).
12.4
Negative Pledge
